Senior Scientist, Analytical Development
Asimov
Summary
We are seeking a Senior Scientist to join our Analytical Sciences team. In this role, you will lead analytical efforts to develop and optimize methods supporting the characterization of antibodies and diverse antibody formats (including bispecifics and other multispecifics, Fc-fusions, and other engineered architectures), proteins, and CGT therapeutics. You will actively collaborate with multiple teams, ensuring that your work and insights are aligned with broader program goals. You will apply your technical skills to address complex analytical challenges, continuously grow your expertise, and contribute to a culture of scientific rigor.
Job description
About the Role
- Lead analytical development efforts for key projects, designing and implementing experiments to generate actionable results.
- Engage with cross-functional teams to share findings, raise critical analytical issues, and support aligned decision-making.
- Manage and mentor junior scientists, focusing on experimental design, problem-solving, and fostering a culture of scientific rigor.
- Ensure transparency and maintain consistent communication with project stakeholders about progress, risks, and results.
- Continuously develop and apply technical skills in analytical method development (HPLC/UPLC, MS, CE, and other protein characterization techniques) to address evolving project needs.
- Identify opportunities to improve workflows, analytical throughput, and reproducibility.
About You
- Ph.D. in Analytical Chemistry, Biochemistry, Molecular Biology, or related field with 4+ years of relevant biopharma analytical experience, or M.S. with 7+ years of relevant experience.
- Hands-on experience in analytical method development (HPLC/UPLC, MS, CE, UV, etc.) across diverse antibody formats, with a willingness and aptitude to rapidly expand technical expertise.
- Strong understanding of antibody structural formats and how format-specific architecture (bispecifics/multispecifics, Fc-fusions, biosimilars, and other engineered constructs) shapes analytical strategy and method selection.
- Strong collaboration and alignment skills, with the ability to communicate findings clearly and maintain transparency with stakeholders.
- Experience mentoring junior scientists, guiding them in experimental design and problem-solving, and fostering a culture of rigorous science.
- Proactive problem-solving mindset, with the ability to apply analytical skills to address complex project challenges.
- Experience engaging across teams and functions, influencing decisions through effective data-driven communication.
- Excellent written and verbal communication skills.
Requirements
- Ph.D. in Analytical Chemistry, Biochemistry, Molecular Biology, or related field with 4+ years of relevant biopharma analytical experience, or M.S. with 7+ years of relevant experience.
- Hands-on experience in analytical method development (HPLC/UPLC, MS, CE, UV, etc.) across diverse antibody formats.
- Strong understanding of antibody structural formats and how format-specific architecture shapes analytical strategy and method selection.
- Strong collaboration and alignment skills, with the ability to communicate findings clearly and maintain transparency with stakeholders.
- Experience mentoring junior scientists, guiding them in experimental design and problem-solving.
- Proactive problem-solving mindset, with the ability to apply analytical skills to address complex project challenges.
- Experience engaging across teams and functions, influencing decisions through effective data-driven communication.
- Excellent written and verbal communication skills.
Benefits
- Stock options
- 401(k) plan
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Career development stipend
- Flexible time-off
- Unlimited sick time
Company overview
Asimov is a pioneering synthetic biology company that builds tools to program living cells through the integration of mammalian synthetic biology, computer-aided design, and machine learning. Founded in 2017 by bioengineers from MIT and Boston University, the company develops an integrated platform combining cells, genetic tools, AI models, and software to design and manufacture next-generation therapeutics including biologics, cell/gene therapies, and RNA-based treatments. Headquartered in Boston, Massachusetts, Asimov's mission is to advance humanity's ability to design living systems, enabling biotechnologies with significant societal benefit. The company has raised over $200 million from top investors including Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company, and has partnered with over 25 companies ranging from small biotechs to major pharmaceutical firms. Asimov's platform includes specialized systems like CHO Edge for biologics production, LV Edge for lentiviral vector manufacturing, and AAV Edge for gene therapy development, consistently delivering high-titer cell lines for advanced therapeutic applications.